Steve Walsh
Principal Scientist - Project Leader Bicycle Therapeutics plc
Steve Walsh completed his Phd and postdoc at University of Cambridge, developing novel bioconjugation strategies, cleavable linkers, and payloads for antibody drug conjugates. Steve is currently a project leader at Bicycle Therapeutics, leading multiple projects from hit ID to Candidate Selection and into IND enabling studies.
Seminars
Wednesday 14th October 2026
Leveraging Bicycle Conjugates as Radio-Imaging & Theragnostic Agents to Inform Early Clinical Therapeutic Development
12:30 pm
- Exploring human data generated from Gallium-68 imaging studies with Bicycle molecules
- Laying out the latest preclinical data of Bicycle Drug Conjugates
- Delving into Gallium-68 PET imaging with Bicycle Molecules to guide clinical development of therapeutic conjugate
